Skip to main content
JKHYJack Henry & Associates, Inc.Sell5.0·$168.37
JKHY · Why this verdict

Why Jack Henry & Associates (JKHY) is rated SELL

Updated

Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.

Show full disclosure ▾

About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.

Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.

Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.

No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.

No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.

Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.

Methodology · Editorial policy & full disclaimer

VerdictSELL
Overall score5.0/10
ConfidenceMEDIUM
MacroRISK_OFF
TrendMatrix Research · core thesis

Engine thesis — one sentence

Jack Henry & Associates demonstrates a rare four-quarter perfect beat streak, high-quality net margins of 21%, and 25.5% upside to the analyst target at a 4-to-1 risk/reward—but a confirmed price downtrend at -2.6% per month slope and elevated leverage create timing risk for new positions despite the quality and asymmetry credentials.

Falsifiable statement — pillar-level invalidators below. Engine-derived; not personalized advice.

Thesis pillars

Net margins of 21%, a Piotroski score of 8 out of 9, and best-in-class margins within the peer group mark this as a high-quality franchise with durable profitability characteristics.

Deteriorating
Quality breakdown
Expectation
Net margins remain above 18% and the Piotroski F-Score stays at or above 7 for the next 4 consecutive reporting periods.

CounterFree cash flow running at 72% of reported net income signals that not all accounting earnings are converting to cash; sustained working capital pressure could widen this gap further and reduce financial flexibility.

Four consecutive quarters of positive earnings surprises averaging 11% above consensus suggest consistent under-promising and over-delivering, a discipline that tends to support multiple expansion over time.

Stable
Catalyst breakdown
Expectation
The beat streak extends to 6 consecutive quarters, with each quarterly surprise remaining at least 5% above consensus.

CounterA consistent beat cadence can reflect conservative guidance-setting rather than genuine business acceleration; if management raises guidance to match the beat pattern, future beats become progressively harder to deliver.

With 25.5% potential upside to the analyst-derived target and a risk/reward ratio of roughly 4-to-1 in the buyer's favor, the setup offers attractive asymmetry for patient capital that can accept the current downtrend risk.

Stable
Price targets
Expectation
Price advances toward $163 within 12 months while the reward-to-risk ratio remains above 2-to-1 throughout.

CounterA favorable upside-to-target ratio can persist without the stock moving if momentum remains negative and no near-term catalyst forces a revaluation; a wide spread to target is not itself a catalyst.

Trading below the 200-day moving average with a confirmed downtrend slope of -2.6% per month, the stock carries technical timing risk regardless of the underlying business quality.

Deteriorating
Momentum breakdown
Expectation
Price reclaims the 200-day moving average within 2 quarters and the monthly slope turns positive, confirming a technical recovery.

CounterAn elevated put/call ratio of 2.71 and rising on-balance volume suggest the options market and institutional buyers are positioning for a recovery; the divergence between bearish price action and accumulation signals has historically preceded trend reversals in high-quality names.

Per-dimension breakdown

Value

5.0/10data confidence 100%
ComponentSub-score
P/E5.3
P/S7.2
EV/EBITDA1.9
Fwd P/E6.0
PEG4.5
Analyst target5.0
  • Forward P/E: 21.3x
  • PEG: 2.04

Quality

7.2/10data confidence 100%
ComponentSub-score
ROE8.0
ROA8.7
Gross margin4.8
Op margin9.0
Net margin9.9
Current ratio4.5
FCF quality5.3
Moat7.1
Piotroski F7.8
  • Strong margins: 20%
  • Earnings quality warning: 70% FCF/NI
  • Strong Piotroski F-Score: 7/9

Growth

1.9/10data confidence 67%
ComponentSub-score
Rev growth3.7
EPS growth0.0

Momentum

3.4/10data confidence 100%
ComponentSub-score
RSI4.4
MACD1.7
OBV1.0
MA position9.0
Volume1.0
  • Overbought (RSI 71)
  • Volume distribution (falling OBV)
  • Above 200-day MA

Sentiment

6.7/10data confidence 100%
ComponentSub-score
Analyst rating7.3
Price target7.0
erm sentiment5.4

Insider

3.9/10data confidence 75%
ComponentSub-score
materiality5.0
holder change3.7
notable moves3.0
  • No net insider activity — $0 (0.000% of mkt cap)

Peer rank

5.6/10data confidence 80%
ComponentSub-score
value rank2.4
quality rank7.9
growth rank3.3
  • Best-in-class margins
  • Conservative debt levels

Technical

4.4/10data confidence 100%
ComponentSub-score
bollinger3.1
support resistance2.6
52w position7.6

Risk (lower is worse)

7.2/10data confidence 100%
ComponentSub-score
short interest6.5
days to cover5.8
volatility4.9
put call7.8
implied vol5.9
beta9.7
debt equity9.8

Catalyst

7.4/10data confidence 100%
ComponentSub-score
erm5.0
earnings history10.0
earnings timing5.0
surprise avg8.3
dividend safety8.5
  • Perfect beat streak: 4Q
  • Dividend aristocrat: 1.4% yield

How the verdict was assembled

Engine trigger

Multiple concerning factors. Consider reducing position.

Engine technical detail
verdict_path: L4:PATH_F_SELL
Passed (5)
  • INSIDER:OK
  • NEWS_EVENTS:NONE_RECENT
  • EARNINGS_PROXIMITY:61d clear
  • SEMI_CYCLE_PEAK:CLEAR
  • MATERIALS_CYCLE_PEAK:CLEAR
Failed (2)
  • MOMENTUM:3.4<4.5
  • ASYMMETRY:0.2<1.5@spot
Warning (1)
  • 8K_CSUITE_CHANGE:5.02 (officer departure/appointment)
Reward-to-Risk
0.24
Upside
+2.8%
Downside
11.4%
Sizing output
AVOID

Setup No clear chart pattern; technical signals are mixed

EdgeNo clear edge No clear edge identified

SuitabilityModerate Balanced profile

Investment implication

The F-path SELL output reflects an overall score of 4.4 below the 5.6 soft trigger — multiple weakening dimensions accumulated rather than a single hard-floor breach. The strongest dimension ( Catalyst at 7.4) was not enough to lift the adjusted overall above the threshold. Co-occurring failed gates ( MOMENTUM:3.4<4.5, ASYMMETRY:0.2<1.5@spot) reinforce the read. Current asymmetry R:R is 0.24 — supplementary context, not the trigger for this path.

The strongest dimensions are Catalyst at 7.4, Quality at 7.2, and Risk (lower is worse) at 7.2; the weakest are Growth at 1.9, Momentum at 3.4, and Insider at 3.9. The V9 engine flagged 2 failed gates with 1 warning, producing an asymmetric reward-to-risk of 0.24 and an engine sizing output of AVOID.

What would invalidate the thesis

Falsifying conditions — when triggered, the corresponding pillar's thesis is invalidated.

  • P1Four Quarter Perfect Beat Streak

    Trip ifEPS surprise falls below 0% for 2 consecutive quarters, breaking the beat streak.

  • P2High Quality Margins Piotroski

    Trip ifNet margin compresses below 15% for 2 consecutive quarters.

  • P3Favorable 25pct Upside Asymmetry

    Trip ifUpside to the analyst target falls below 10% for 4 consecutive weeks, indicating the stock has materially recovered or the target was cut.

  • P4Confirmed Downtrend Timing Risk

    Trip ifPrice reclaims and sustains above the 200-day moving average for 4 consecutive weeks.

Engine reasoning is mechanically derived from pipeline gate outputs. See decision view.

Home Stocks JKHY Why this verdict